A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
Clinical trial NCT05486065 · COMPLETED
Trial details
- NCT number
- NCT05486065
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2023-10-12
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.